ArticleChild and adolescent mental health2025
Commentary: How do we get platforms to share data with independent researchers? Regulation alone will not cut it: a commentary on Livingston et al. (2023), Bourgaize et al. (2025).
Article in Child and adolescent mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We respond to articles in the Child and Adolescent Mental Health journal about whether, and under what, conditions researchers should collaborate with digital companies. In particular, we discuss the challenges academics face to access and study platform data. Independent academic research in this area is crucial for identifying and combating any potential negative effects that platforms can have on individuals and societies. Past discussions on academic data access have focused on platform regulation and data governance. However, in this commentary, we argue that even if key stakeholders agree on a regulatory and governance model, platforms have strong incentives to not comply-or to comply only partially. We advocate for a more holistic strategy aiming at influencing regulation, public opinion, news media, diverse political groups and for building a robust oversight structure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.